Report Thumbnail
Product Code LP0912411527R3
Published Date 2026/2/10
English75 PagesGlobal

Global Bioradar Market Growth 2026-2032 ‐ MedicalDevice / MedTech Market


Report Thumbnail
Product Code LP0912411527R3◆An updated version may be available. We will check for you.
Published Date 2026/2/10
English 75 PagesGlobal

Global Bioradar Market Growth 2026-2032 ‐ MedicalDevice / MedTech Market



Abstract

This report provides a comprehensive analysis of the global Bioradar market, focusing on K-band millimeter-wave radar technology used for non-contact physiological monitoring. It examines market dynamics, including key drivers and trends across medical and pathological applications, while offering detailed forecasts through 2032. The study evaluates competitive landscapes, segmentation by type and application, and regional growth patterns across the Americas, APAC, and Europe. Additionally, it profiles leading industry players and analyzes strategic developments to identify emerging opportunities.

Related Questions

Omesoft, BioRadar, HKLife, Vital Signs Solutions


Summary

Executive Overview

Global Market Outlook

The global Bioradar market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Technology Definition

Bio-radar refers to K-band millimeter-wave radar technology. It utilizes 24GHz radar waves to scan the human body. The reflected radar waves capture vital signals, including human body movement, breathing, and heartbeat. By analyzing these specific physiological signs, the health and physiological status of the human body can be assessed.

Report Scope and Methodology

Produced by LP Information, Inc. (LPI), the “Bioradar Industry Forecast” examines historical sales and reviews total global Bioradar sales in 2025. The report provides a comprehensive analysis of projected Bioradar sales from 2026 through 2032, segmented by region, market sector, and sub-sector. All financial analyses are provided in US$ millions.

This Insight Report offers a thorough evaluation of the global Bioradar landscape, highlighting key trends in:

  • Product segmentation
  • Company formation
  • Revenue and market share
  • Latest developments
  • Mergers and Acquisitions (M&A) activity

The report also analyzes the strategies of leading global companies, focusing on their Bioradar portfolios and capabilities, market entry strategies, market positions, and geographic footprints to understand their unique standing in an accelerating global market. Utilizing a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, the study provides a nuanced view of the current state and future trajectory of the industry.

Market Segmentation

By Type

  • Non-contact Bio-radar
  • Contact Bioradar

By Application

  • Medicine
  • Pathology
  • Others

By Geography

  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

Regional Market Analysis

  • United States: The market is estimated to see sustained growth from 2025 through 2032.
  • China: The market is estimated to see sustained growth from 2025 through 2032.
  • Europe: The market is estimated to see sustained growth from 2025 through 2032.

Competitive Landscape

Key Vendors

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolios, and market penetration:

  • Omesoft
  • BioRadar
  • HKLife
  • Vital Signs Solutions

Market Share

In 2025, the two largest global companies in the Bioradar sector held a significant portion of the total market revenue.

Key Questions Addressed

  • What is the 10-year outlook for the global Bioradar market?
  • What factors are driving Bioradar market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Bioradar market opportunities vary by end market size?
  • How does Bioradar break out by Type and by Application?

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global Bioradar Annual Sales 2021-2032
      • 2.1.2 World Current & Future Analysis for Bioradar by Geographic Region, 2021, 2025 & 2032
      • 2.1.3 World Current & Future Analysis for Bioradar by Country/Region, 2021, 2025 & 2032
    • 2.2 Bioradar Segment by Type
      • 2.2.1 Non-contact Bio-radar
      • 2.2.2 Contact Bioradar
      • 2.2.3 Bioradar Sales by Type
        • 2.2.3.1 Global Bioradar Sales Market Share by Type (2021-2026)
        • 2.2.3.2 Global Bioradar Revenue and Market Share by Type (2021-2026)
        • 2.2.3.3 Global Bioradar Sale Price by Type (2021-2026)
    • 2.3 Bioradar Segment by Application
      • 2.3.1 Medicine
      • 2.3.2 Pathology
      • 2.3.3 Others
      • 2.3.4 Bioradar Sales by Application
        • 2.3.4.1 Global Bioradar Sale Market Share by Application (2021-2026)
        • 2.3.4.2 Global Bioradar Revenue and Market Share by Application (2021-2026)
        • 2.3.4.3 Global Bioradar Sale Price by Application (2021-2026)
  • 3 Global by Company

    • 3.1 Global Bioradar Breakdown Data by Company
      • 3.1.1 Global Bioradar Annual Sales by Company (2021-2026)
      • 3.1.2 Global Bioradar Sales Market Share by Company (2021-2026)
    • 3.2 Global Bioradar Annual Revenue by Company (2021-2026)
      • 3.2.1 Global Bioradar Revenue by Company (2021-2026)
      • 3.2.2 Global Bioradar Revenue Market Share by Company (2021-2026)
    • 3.3 Global Bioradar Sale Price by Company
    • 3.4 Key Manufacturers Bioradar Producing Area Distribution, Sales Area, Product Type
      • 3.4.1 Key Manufacturers Bioradar Product Location Distribution
      • 3.4.2 Players Bioradar Products Offered
    • 3.5 Market Concentration Rate Analysis
      • 3.5.1 Competition Landscape Analysis
      • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
    • 3.6 New Products and Potential Entrants
    • 3.7 Market M&A Activity & Strategy
  • 4 World Historic Review for Bioradar by Geographic Region

    • 4.1 World Historic Bioradar Market Size by Geographic Region (2021-2026)
      • 4.1.1 Global Bioradar Annual Sales by Geographic Region (2021-2026)
      • 4.1.2 Global Bioradar Annual Revenue by Geographic Region (2021-2026)
    • 4.2 World Historic Bioradar Market Size by Country/Region (2021-2026)
      • 4.2.1 Global Bioradar Annual Sales by Country/Region (2021-2026)
      • 4.2.2 Global Bioradar Annual Revenue by Country/Region (2021-2026)
    • 4.3 Americas Bioradar Sales Growth
    • 4.4 APAC Bioradar Sales Growth
    • 4.5 Europe Bioradar Sales Growth
    • 4.6 Middle East & Africa Bioradar Sales Growth
  • 5 Americas

    • 5.1 Americas Bioradar Sales by Country
      • 5.1.1 Americas Bioradar Sales by Country (2021-2026)
      • 5.1.2 Americas Bioradar Revenue by Country (2021-2026)
    • 5.2 Americas Bioradar Sales by Type (2021-2026)
    • 5.3 Americas Bioradar Sales by Application (2021-2026)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC Bioradar Sales by Region
      • 6.1.1 APAC Bioradar Sales by Region (2021-2026)
      • 6.1.2 APAC Bioradar Revenue by Region (2021-2026)
    • 6.2 APAC Bioradar Sales by Type (2021-2026)
    • 6.3 APAC Bioradar Sales by Application (2021-2026)
    • 6.4 China
    • 6.5 Japan
    • 6.6 South Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
    • 6.10 China Taiwan
  • 7 Europe

    • 7.1 Europe Bioradar by Country
      • 7.1.1 Europe Bioradar Sales by Country (2021-2026)
      • 7.1.2 Europe Bioradar Revenue by Country (2021-2026)
    • 7.2 Europe Bioradar Sales by Type (2021-2026)
    • 7.3 Europe Bioradar Sales by Application (2021-2026)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa Bioradar by Country
      • 8.1.1 Middle East & Africa Bioradar Sales by Country (2021-2026)
      • 8.1.2 Middle East & Africa Bioradar Revenue by Country (2021-2026)
    • 8.2 Middle East & Africa Bioradar Sales by Type (2021-2026)
    • 8.3 Middle East & Africa Bioradar Sales by Application (2021-2026)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Manufacturing Cost Structure Analysis

    • 10.1 Raw Material and Suppliers
    • 10.2 Manufacturing Cost Structure Analysis of Bioradar
    • 10.3 Manufacturing Process Analysis of Bioradar
    • 10.4 Industry Chain Structure of Bioradar
  • 11 Marketing, Distributors and Customer

    • 11.1 Sales Channel
      • 11.1.1 Direct Channels
      • 11.1.2 Indirect Channels
    • 11.2 Bioradar Distributors
    • 11.3 Bioradar Customer
  • 12 World Forecast Review for Bioradar by Geographic Region

    • 12.1 Global Bioradar Market Size Forecast by Region
      • 12.1.1 Global Bioradar Forecast by Region (2027-2032)
      • 12.1.2 Global Bioradar Annual Revenue Forecast by Region (2027-2032)
    • 12.2 Americas Forecast by Country (2027-2032)
    • 12.3 APAC Forecast by Region (2027-2032)
    • 12.4 Europe Forecast by Country (2027-2032)
    • 12.5 Middle East & Africa Forecast by Country (2027-2032)
    • 12.6 Global Bioradar Forecast by Type (2027-2032)
    • 12.7 Global Bioradar Forecast by Application (2027-2032)
  • 13 Key Players Analysis

    • 13.1 Omesoft
      • 13.1.1 Omesoft Company Information
      • 13.1.2 Omesoft Bioradar Product Portfolios and Specifications
      • 13.1.3 Omesoft Bioradar Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.1.4 Omesoft Main Business Overview
      • 13.1.5 Omesoft Latest Developments
    • 13.2 BioRadar
      • 13.2.1 BioRadar Company Information
      • 13.2.2 BioRadar Bioradar Product Portfolios and Specifications
      • 13.2.3 BioRadar Bioradar Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.2.4 BioRadar Main Business Overview
      • 13.2.5 BioRadar Latest Developments
    • 13.3 HKLife
      • 13.3.1 HKLife Company Information
      • 13.3.2 HKLife Bioradar Product Portfolios and Specifications
      • 13.3.3 HKLife Bioradar Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.3.4 HKLife Main Business Overview
      • 13.3.5 HKLife Latest Developments
    • 13.4 Vital Signs Solutions
      • 13.4.1 Vital Signs Solutions Company Information
      • 13.4.2 Vital Signs Solutions Bioradar Product Portfolios and Specifications
      • 13.4.3 Vital Signs Solutions Bioradar Sales, Revenue, Price and Gross Margin (2021-2026)
      • 13.4.4 Vital Signs Solutions Main Business Overview
      • 13.4.5 Vital Signs Solutions Latest Developments
  • 14 Research Findings and Conclusion

USD 7,320 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.